HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An optimized lactate dehydrogenase release assay for screening of drug candidates in neuroscience.

AbstractINTRODUCTION:
Quantification of lactate dehydrogenase (LDH) release is a widely accepted assay for the quantitative determination of cell viability and late-stage apoptosis. Major disadvantages of commercially available LDH assay kits include proprietary formulations, limited options for optimization and high cost, all resulting in limited reproducibility in research applications. Here, we describe a novel, custom LDH assay suitable in the context of plate reader-based screening of drug candidates for glioprotection, but with wide applicability to other cell types and experimental paradigms.
METHODS:
We developed a novel and highly reproducible LDH release assay that is more cost-effective than commercially available assays with comparable performance. The assay was validated by assessing 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid antioxidant protection against tert-butylhydroperoxide-induced oxidative stress in C6 astroglioma cells. Assay performance was validated by direct comparison and compatible with other methods of measuring cellular viability, namely 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and 6-carboxy-2', 7' dichlorodihydrofluorescein diacetate assays.
RESULTS:
There was no statistically significant difference between results obtained with the novel custom assay and a commercially available assay CytoTox96® (Promega, Madison, WI).
DISCUSSION:
The novel custom LDH release assay allows the reproducible quantification of cell viability and is highly cost-effective when compared to commercially available assays (approximately 25 times cheaper). In addition and in contrast to commercially available assays, the identification and detailed description of all assay components and procedures provide greater control over experimental conditions and design. We provide a detailed standard operating procedure permitting our novel assay to be readily adapted depending on experimental requirements.
AuthorsSimon Kaja, Andrew J Payne, Tulsi Singh, Jasleen K Ghuman, Erin G Sieck, Peter Koulen
JournalJournal of pharmacological and toxicological methods (J Pharmacol Toxicol Methods) 2015 May-Jun Vol. 73 Pg. 1-6 ISSN: 1873-488X [Electronic] United States
PMID25681780 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Antioxidants
  • Reactive Oxygen Species
  • tert-Butylhydroperoxide
  • L-Lactate Dehydrogenase
Topics
  • Antioxidants (pharmacology)
  • Cell Line, Tumor
  • Cell Survival (drug effects, physiology)
  • Drug Evaluation, Preclinical (methods)
  • Humans
  • L-Lactate Dehydrogenase (antagonists & inhibitors, metabolism)
  • Neurosciences
  • Reactive Oxygen Species (metabolism)
  • tert-Butylhydroperoxide (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: